Puerperal widespread pyomyositis after group A streptococcal toxic shock syndrome.
Feigenberg
Tomer
T
Department of Obstetrics and Gynecology, Hadassah-Hebrew University Medical Center, Jerusalem, Israel. feigenberg@013.net
Sela
Hen Y
HY
Applbaum
Yaakov H
YH
Mankuta
David
D
D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002981:Clindamycin / Q000627:therapeutic use; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D052880:Pyomyositis / Q000188:drug therapy / Q000209:etiology / Q000382:microbiology*; D012772:Shock, Septic / Q000150:complications / Q000188:drug therapy / Q000382:microbiology*; D013290:Streptococcal Infections / Q000382:microbiology*; D013297:Streptococcus pyogenes; D013997:Time Factors
D000900:Anti-Bacterial Agents; D016756:Immunoglobulins, Intravenous; D002981:Clindamycin; D002443:Ceftriaxone